Keyphrases
Cannabinoid Receptor 1 (CB1R)
100%
Renal Tubular Epithelial Cells
61%
Obesity
58%
Kidney
52%
Diabetes
46%
Endocannabinoids
35%
Mammalian Target of Rapamycin (mTOR)
34%
Diabetic Nephropathy
30%
Diabetic Kidney Disease
29%
Glucose Transporter 2 (GLUT2)
22%
Kidney Disease
22%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
20%
Chronic Kidney Disease
20%
Diabesity
20%
Therapeutic Potential
20%
Kidney Proximal Tubule
18%
CB1 Receptor
17%
Receptor System
14%
Receptor Blockade
14%
Glucose Reabsorption
14%
Endocannabinoid System
14%
Proximal Tubule
13%
Inducible Nitric Oxide Synthase
13%
Kidney Function
13%
Pathophysiology
13%
Metabolic
13%
Metabolic Abnormalities
13%
Graft-versus-host Disease (GvHD)
13%
Bone Mass
12%
Bone Remodeling
12%
Medicine and Dentistry
Cannabinoid 1 Receptor
76%
Diabetic Nephropathy
45%
Diabetes
43%
Endocannabinoid
39%
Receptor
26%
Glucose Transporter 2
22%
Sodium Glucose Cotransporter 2 Inhibitor
20%
Chronic Kidney Disease
20%
Nephropathy
18%
Kidney Function
17%
Kidney Proximal Tubule
16%
Diet Induced Obesity
15%
Receptor Blocking
15%
Methionine
14%
Endocannabinoid System
14%
Pathophysiology
13%
Sodium Glucose Cotransporter 2
13%
Bone Remodeling
12%
Cannabinoid
12%
Osteoplasty
12%
Mammalian Target of Rapamycin Complex 1
11%
Leptin Receptor
10%
Cystitis
10%
Cell Therapy
10%
Mesenchymal Stem Cell
10%
Leptin
10%
Graft Versus Host Reaction
10%
Kidney Tubule Function
10%
Insulitis
10%
Ischemia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 1 Receptor
82%
Endocannabinoid
40%
Diabetic Nephropathy
36%
Sodium Glucose Cotransporter 2 Inhibitor
20%
Chronic Kidney Failure
20%
Glucose Transporter 2
16%
Diet Induced Obesity
16%
Cannabinoid 1 Receptor Antagonist
16%
Fatty Liver
15%
Receptor
14%
Endocannabinoid System
14%
Cytokine
11%
Sodium Glucose Cotransporter 2
10%
Mammalian Target of Rapamycin Complex 1
10%
Leptin
10%
Leptin Receptor
10%
Ischemia
10%
Rimonabant
10%
Cystitis
10%
Nanoparticle
10%
Graft Versus Host Reaction
10%
Pathophysiology
10%
Bilirubin
10%